Treatment of Serous Macular Detachment Associated With Circumscribed Choroidal Hemangioma

Role of Radiation Therapy for Choroidal Hemangioma: A Brief Review

“…It is helpful in total reabsorption of serous retinal detachment thereby re-attaching the retina and improving the visual acuity. The disadvantages of TTT are CME, choroidal atrophy, RPE hypertrophy, pre-retinal fibrosis, focal iris atrophy and retinal vascular occlusions [8,9,33].…”

“…Intravitreal anti-VEGF agents (bevacizumab, ranibizumab, pegaptanib) is an alternate treatment choice in CH patients who develop visual complications with laser photocoagulation or TTT [31][32][33][34]. They can be used either as a primary treatment option or along with PDT and plaque brachytherapy.…”

Clinical outcomes and predictors of response to photodynamic therapy in symptomatic circumscribed choroidal hemangioma: A retrospective case series

“…Interest in the different protocols of PDT or with other treatment approaches for CCHs is increasing. Some studies have demonstrated that the intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF), such as bevacizumab or ranibizumab, may be effective in treating patients with CCH when applied alone or in combination with PDT, particularly in the presence of subretinal fluid (SRF) accumulation [ 13 , 14 , 15 , 16 ]. Herein, we report the visual and anatomical outcomes of 20 patients with symptomatic CCH who were treated with PDT, either as monotherapy or in combination with other treatments.…”

Imaging of retinal and choroidal vascular tumours

“…SD-OCT, therefore, is useful for monitoring treatment response, for example, regression of macular oedema or exudative retinal detachment. 29 Recurrent subretinal fluid following therapy can be detected before the vision deteriorates and before this fluid becomes apparent clinically. 29,30 At baseline, SD-OCT images can also be used to distinguish acute (exudative detachment with preserved retinal architecture) from chronic changes (retinal atrophy).…”

“…29 Recurrent subretinal fluid following therapy can be detected before the vision deteriorates and before this fluid becomes apparent clinically. 29,30 At baseline, SD-OCT images can also be used to distinguish acute (exudative detachment with preserved retinal architecture) from chronic changes (retinal atrophy). Together with the evaluation of the inner segment/ outer segment photoreceptor line and the integrity of the RPE layer, this information may be useful when considering treatment options and potential outcome (Figure 3).…”